17 Apr 2018

The Facts About CBD In The UK. April 2018.

This article is an update to 'The Facts About CBD In The UK. December 2016.' The past three years have seen a true phenomenon develop around the cannabis law reform movement which has quickly crossed into mainstream society, commerce and general awareness. It's the explosion of the CBD market, a trade that has grown from zero to £50 million per annum in the UK in this very short period. There has been a great deal of nonsense published about the market, the...

12:30 / Economy & Business / Law / Medicinal Campaign / Medicine / Peter Reynolds
1 Like
26 Comments
06 Dec 2016

The Facts About CBD In The UK. December 2016.

On 3rd October 2016 the Medicines and Healthcare products Regulatory Agency (MHRA)  issued notices to a number of CBD suppliers stating that cannabidiol (CBD) was being designated as a medicine and that sale of all CBD products must stop within 28 days, ostensibly by the 1st November. A lot has happened since.  Most importantly, the Cannabis Trades Association UK (CTAUK) has been established to represent the industry and protect the interests of CBD consumers but there remains great confusion as to the legal status of CBD...

10:33 / Medicinal Campaign / Medicine / News / Politics / Science / Peter Reynolds
24 Likes
18 Comments
04 Nov 2016

Report Of Meeting With MHRA On Regulation of Cannabidiol (CBD).

Yesterday, 3rd November 2016, six delegates from the UK Cannabis Trade Association (UKCTA) met with Medicines and Health Products Regulatory Agency (MHRA) representatives at the agency's headquarters in Victoria. We were courteously received. The meeting was cordial, productive and enabled both sides to clarify their positions and better understand each other's perspective. In...

14:44 / Medicine / News / Politics / Science / Peter Reynolds
22 Likes
6 Comments
01 Nov 2016

MHRA Backtracking Super Fast On CBD Ban.

In advance of the meeting between the UK Cannabis Trade Association (UKCTA) and the MHRA on Thursday, there has been a flurry of activity which amounts to a climb down by the regulator. This statement was published on the MHRA website at lunchtime today. "Update 1 November 2016 An MHRA spokesperson said: While MHRA has given its opinion that products containing cannabidiol (CBD) used for medical purposes are medicines, we have also carefully considered the needs of individuals using CBD products to treat or manage the...

16:43 / Medicine / News / Politics / Peter Reynolds
23 Likes
3 Comments
30 Oct 2016

UK Cannabis Trade Association Meeting With MHRA This Week.

After all the speculation, many misleading and false reports and a plethora of attempts to interpret the MHRA's actions concerning cannabidiol (CBD), this week the chips are down. On Thursday 3rd November, at MHRA headquarters in Victoria, six representatives of the UK Cannabis Trade Association (UKCTA) will sit down with those responsible for the agency's statements on CBD. We will be armed with counsel's opinion on the legality of the MHRA's action but most importantly we...

17:09 / Medicine / News / Politics / Peter Reynolds
17 Likes
0 Comments
19 Oct 2016

MHRA Confirms Meeting With CBD Industry Representatives.

Today, the Medicines and Healthcare products Regulatory Agency (MHRA), has arranged a meeting with representatives from the UK Cannabis Trade Association (UKCTA) to discuss its designation of cannabidiol (CBD) as a medicine. A request for a meeting was was first made in writing on 20th September 2016, when the possibility of the MHRA's action was still little more than a rumour.  Nearly six weeks later, after repeated requests, complaints and lobbying from many companies, individuals and MPs, the meeting has been fixed for 3rd November...

17:12 / Medicine / News / Politics / Peter Reynolds
14 Likes
0 Comments
15 Oct 2016

The British Medical Journal (BMJ) Features The CLEAR Medicinal Cannabis Campaign.

"Muddled thinking" over cannabis leaves patients in limbo, warn campaigners BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i5556 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5556 Download PDF here Companies selling cannabis based products have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products. Campaigners for cannabis law reform welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that...

07:27 / Medicine / News / Politics / Peter Reynolds
20 Likes
3 Comments
12 Oct 2016

The Man From The MHRA. Endangering Public Health With Precipitate Action On CBD.

The Medicines and Healthcare Products Regulatory Agency (MHRA) apparent decision to designate cannabidiol (CBD) as a medicine is an unholy mess and has been handled about as badly as it is possible for a government agency to deal with a matter of public safety. The desk of Dr Ian Hudson, the Chief Executive, will shortly be groaning under the weight of correspondence from MPs asking him to explain exactly what is going on.  We know that...

17:08 / Medicine / News / Politics / Peter Reynolds
18 Likes
8 Comments